If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
333.50    0.00 (0.00%)
Bid:
332.00
Ask:
335.00
Spread: 3.00 (0.904%)
Market Cap: £230.27m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

Form 8.5 (EPT/RI)

9 Jun 2026 12:00

RNS Number : 5719H
Panmure Liberum Limited
09 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Animalcare Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Animalcare Group plc

(d) Date dealing undertaken:

08 Jun 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

20p ordinary

Purchase

6,600

3.3188 GBP

3.3188 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

09/06/2026

Contact name:

Paul Crispin

Telephone number:

+44 (0) 20 7886 2759

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERMZGGVRLZGVZG
Date   Source Headline
19th Sep 20177:00 amRNSHolding(s) in Company
18th Aug 20179:53 amRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSTrading update & Notice of Interim Results
20th Jul 20179:42 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSHolding(s) in Company
17th Jul 20177:00 amRNSHolding(s) in Company
14th Jul 20173:30 pmRNSHolding(s) in Company
13th Jul 20178:01 amRNSCompletion of Acquisition and Readmission to AIM
12th Jul 201710:40 amRNSResult of General Meeting, Issue of Equity ...
27th Jun 20179:30 amRNSSchedule One - Animalcare Group Plc
26th Jun 20177:30 amRNSRestoration - Animalcare Group Plc
26th Jun 20177:00 amRNSRestoration of Trading on AIM
23rd Jun 20173:11 pmRNSResults of Placing
23rd Jun 20177:30 amRNSSuspension - Animalcare Group Plc
23rd Jun 20177:00 amRNSProposed Acquisition of Ecuphar NV and Placing
5th Apr 20178:00 amRNSHolding(s) in Company
15th Feb 20177:00 amRNSHalf-year Report
9th Jan 20177:00 amRNSTrading update & Notice of Interim Results
21st Nov 20165:29 pmRNSHolding(s) in Company
15th Nov 20163:09 pmRNSResult of AGM
13th Oct 20166:02 pmRNSDirector/PDMR Shareholding & Additional Listing
12th Oct 20167:00 amRNSFinal Results
22nd Aug 20165:16 pmRNSHolding(s) in Company
19th Jul 20165:45 pmRNSAdditional Listing & Directors Dealing
14th Jul 20167:00 amRNSTrading Update & Notice of Results
2nd Jun 20165:58 pmRNSHolding(s) in Company
31st May 20164:45 pmRNSAdditional Listing
7th Apr 20162:43 pmRNSHolding(s) in Company
24th Mar 20166:22 pmRNSHolding(s) in Company
10th Feb 20167:00 amRNSHalf Yearly Report
20th Jan 20167:00 amRNSTrading Update & Notice of Interim Results
23rd Dec 20158:43 amRNSDirector/PDMR Shareholding
8th Dec 20156:05 pmRNSDirector/PDMR Shareholding
7th Dec 20156:00 pmRNSDirector/PDMR Shareholding
1st Dec 20152:31 pmRNSAdditional Listing and Total Voting Rights
23rd Nov 20155:55 pmRNSDirector/PDMR Shareholding
17th Nov 20152:09 pmRNSResult of AGM
11th Nov 20159:23 amRNSAdditional Listing and Total Voting Rights
14th Oct 20157:00 amRNSFinal Results
7th Aug 20154:36 pmRNSAdditional Listing
9th Jul 20157:00 amRNSTrading Update & Notice of Results
3rd Jun 20157:00 amRNSHolding(s) in Company
2nd Jun 20154:06 pmRNSDirectorate Change
9th Apr 20152:15 pmRNSHolding(s) in Company
9th Mar 201510:50 amRNSAdditional Listing
24th Feb 20157:00 amRNSHalf Yearly Report
9th Feb 20157:00 amRNSDirectorate Change
14th Jan 20157:00 amRNSTrading Update & Notice of Results
28th Nov 201410:57 amRNSDirector/PDMR Shareholding
26th Nov 20142:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.